Aspen Aerogels, Inc. (NYSE:ASPN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has been given an average rating of "Moderate Buy" by the eleven ratings firms that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $19.11.

Several analysts recently issued reports on the stock. Craig Hallum reduced their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Canaccord Genuity Group lowered their target price on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research note on Friday, February 14th. Oppenheimer downgraded shares of Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. B. Riley lowered their price objective on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a research report on Wednesday, February 19th. Finally, Seaport Res Ptn downgraded shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th.

Insider Buying and Selling at Aspen Aerogels

In related news, CEO Donald R. Young bought 20,000 shares of the business's stock in a transaction on Monday, May 12th. The shares were purchased at an average cost of $5.35 per share, with a total value of $107,000.00. Following the acquisition, the chief executive officer now owns 550,856 shares of the company's stock, valued at $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 4.30% of the company's stock.

Institutional Trading of Aspen Aerogels

Institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in shares of Aspen Aerogels by 5.5% in the 4th quarter. Vanguard Group Inc. now owns 4,360,246 shares of the construction company's stock worth $51,800,000 after purchasing an additional 226,251 shares during the period. Barclays PLC boosted its holdings in shares of Aspen Aerogels by 16.8% during the 4th quarter. Barclays PLC now owns 107,764 shares of the construction company's stock worth $1,280,000 after buying an additional 15,462 shares in the last quarter. BNP Paribas Financial Markets grew its position in shares of Aspen Aerogels by 645.4% during the 4th quarter. BNP Paribas Financial Markets now owns 135,584 shares of the construction company's stock worth $1,611,000 after buying an additional 117,395 shares during the period. Swiss National Bank grew its position in shares of Aspen Aerogels by 1.9% during the 4th quarter. Swiss National Bank now owns 128,800 shares of the construction company's stock worth $1,530,000 after buying an additional 2,400 shares during the period. Finally, MetLife Investment Management LLC lifted its position in shares of Aspen Aerogels by 6.3% during the 4th quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company's stock valued at $425,000 after acquiring an additional 2,118 shares during the period. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Stock Performance

Shares of Aspen Aerogels stock traded up $0.27 on Friday, hitting $6.66. The stock had a trading volume of 2,888,120 shares, compared to its average volume of 2,001,609. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The stock has a market cap of $546.82 million, a price-to-earnings ratio of 41.63 and a beta of 2.72. The business's 50 day moving average is $5.78 and its two-hundred day moving average is $9.55. Aspen Aerogels has a twelve month low of $4.16 and a twelve month high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.01. The business had revenue of $78.72 million during the quarter, compared to analysts' expectations of $82.75 million. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The firm's revenue for the quarter was down 16.7% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.02) earnings per share. Analysts forecast that Aspen Aerogels will post 0.17 EPS for the current year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.